• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON CLAREON VIVITY EXTENDED VISION UV ABSORBING IOL; EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON CLAREON VIVITY EXTENDED VISION UV ABSORBING IOL; EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS Back to Search Results
Model Number CCWET0
Medical Device Problem Code Scratched Material (3020)
Health Effect - Clinical Codes Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/15/2023
Type of Reportable Event Malfunction
Event or Problem Description
A nurse reported during intraocular lens (iol) implant procedure, upon insertion of iol, a scratched was noted on iol.The lens was explanted and replaced with another lens during initial procedure.The procedure was completed on same day.Additional information has been requested.
 
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Additional information has been received stating no patient harm.
 
Additional Manufacturer Narrative
The lens was returned loose in a ziploc bag with the disassembled lens case inside the lens carton.Solution and blood were dried on the lens.The lens was cut into pieces, typical of an insertion and removal.One haptic was broken in the gusset area.The broken haptic was not returned.One optic portion has a linear scratch located on the posterior surface.The other optic portion has cracked damaged at the optic edge.Product history records were reviewed and the documentation indicated the product met release criteria.The account indicated the use of qualified associated products.The reported scratch was observed.The optic was cut into pieces, typical of damage created to remove a lens from the eye.All lenses are 100 percentage (%) inspected for cosmetic attributes and the damage exhibited by the returned complaint sample would not have met company release criteria.Based on our observation, it can be reasonably concluded that the damage is not manufacturing related.Due to the presence of surgical solution, blood, and the condition of the returned sample, the damage is most likely related to customer handling.Information was provided that there was a lot of staff turnover.Four intraocular lens iol lens loading in-services were conducted at the reporting facility between june 2023 to october 2023.Customer affairs manager (cam) has continued to spend a lot of time in the operation room (or) with the surgeon and staff.They have stated many times that the loads have been very good over the last 4 to 6 months.Cam followed up and they reemphasized again that the loads have been good now that they have staff consistency.They never felt like it was a quality issue but rather a loading/staff issue.The instruction for use (ifu) instructs: using holding forceps, grasp the lens by the optic edge and gently place the lens anterior side up into the back of the ophthalmic viscosurgical device (ovd)-filled cartridge.The lens should be inserted until the optic is a little more than half-way inside the cartridge.Use the holding forceps to gently push down on the lens, verifying that the lens is on the bottom surface of the cartridge.Using holding forceps, take the trailing haptic, and gently fold the haptic onto the anterior side of the optic.Slowly grip or push the optic edge to position the lens as far into the cartridge as the forceps will permit, while ensuring the lens remains on the bottom surface of the cartridge and the trailing haptic remains on the optic.Failure to follow these steps may cause the lens to advance incorrectly causing delivery issues and/or damage.The ifu instructs: follow the section regarding directions for use for information on the maximum allowed time for the iol to stay in the folded condition.Failure to adhere to manufacturer¿s recommendations may result in iol damage.Ifu note: during lens loading and insertion, do not allow the iol to remain in a folded condition within the selected iol delivery system for more than 3 minutes prior to completing insertion into the capsular bag.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON VIVITY EXTENDED VISION UV ABSORBING IOL
Common Device Name
EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key18825825
Report Number1119421-2024-00386
Device Sequence Number7879345
Product Code POE
UDI-Device Identifier00380652405799
UDI-Public00380652405799
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 05/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberCCWET0
Device Catalogue NumberCCWET0.210
Device Lot Number15597976
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 02/06/2024
Supplement Date Received by Manufacturer04/10/2024
Initial Report FDA Received Date03/04/2024
Supplement Report FDA Received Date05/08/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/20/2023
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CLAREON MONARCH IV INJECTOR; DUOVISC; MONARCH III CARTRIDGE D; UNSPECIFIED REPLACEMENT LENS
Patient Age68 YR
Patient SexMale
-
-